Funding Opportunity

Funding Opportunity - page 9

Showing 97–108 of 263 funding opportunities · Page 9 of 22

Artificial Intelligence For Qatar – 1st Cycle

Each award is up to QAR 500.000 per year for up to two years. - Wednesday, 14 January, 2026 Submission opens and Wednesday, 11 March 2026 Submission deadline

Qatar Research Development and Innovation Council (QRDI)
The call aims to address the following research priorities: · Artificial Intelligence Assisted Healthcare · Artificial Intelligence Assisted Education · Artificial Intelligence Assisted Tourism

Funding Opportunity: Artificial Intelligence For Qatar – 1st Cycle

Read more: Artificial Intelligence For Qatar – 1st Cycle

Voices Through Time – 1st Cycle

Each award is up to QAR 547.500 per year for up to two years. - Wednesday January 14, 2026 Submission opens, Wednesday March 11, 2026 Submission deadline

Qatar Research Development and Innovation Council (QRDI)
The call aims to address the following research priorities: ·National Collection- Documentation and Analysis · National Collection - Utilization and Outreach · The Economics of Heritage

Funding Opportunity: Voices Through Time – 1st Cycle

Read more: Voices Through Time – 1st Cycle

Funding Opportunity: IN VITRO DISEASE MODELING: TYPE I DIABETES-ON-A-CHIP PLATFORMS FOR TRANSLATIONAL RESEARCH

Read more: IN VITRO DISEASE MODELING: TYPE I DIABETES-ON-A-CHIP PLATFORMS FOR TRANSLATIONAL RESEARCH

Funding Opportunity: TRANSLATIONAL STRATEGIES TO DEFINE, ENHANCE, AND MONITOR VASCULARIZATION FOR DURABLE ISLET REPLACEMENT THERAPIES

Read more: TRANSLATIONAL STRATEGIES TO DEFINE, ENHANCE, AND MONITOR VASCULARIZATION FOR DURABLE ISLET REPLACEMENT THERAPIES

GRANT PROGRAM

$150,000, indirect costs of up to 8% are allowed. - Friday, February 27, 2026 (LOI)

Foundation for Prader-Willi Research
The Foundation for Prader-Willi Research (FPWR) is dedicated to supporting research to advance the understanding and treatment of Prader-Willi syndrome (PWS).

Funding Opportunity: GRANT PROGRAM

Read more: GRANT PROGRAM

ROBERT A. KYLE CAREER DEVELOPMENT AWARD GRANT

Up to $160,000, inclusive of 5% for indirect costs. - February 27, 2026 (RFP)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)
The aim of this grant is to provide support to talented young investigators with a background in hematology and/or oncology, encouraging them to either enter or continue WM research.

Funding Opportunity: ROBERT A. KYLE CAREER DEVELOPMENT AWARD GRANT

Read more: ROBERT A. KYLE CAREER DEVELOPMENT AWARD GRANT

ACCELERATION AND EXPANSION RESEARCH GRANTS

Total Grant Award of $250,000 over 2 years. - February 27, 2026 (RFP)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)
These grants aim to support research studies to accelerate existing and additional IWMF Grants.

Funding Opportunity: ACCELERATION AND EXPANSION RESEARCH GRANTS

Read more: ACCELERATION AND EXPANSION RESEARCH GRANTS

CORRELATIVE COMPANION RESEARCH GRANTS

Total Grant Award of up to $250,000. - February 27, 2026 (RFP)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)
IWMF seeks to support correlative companion research studies within pharmaceutical and biotechnology company.

Funding Opportunity: CORRELATIVE COMPANION RESEARCH GRANTS

Read more: CORRELATIVE COMPANION RESEARCH GRANTS

TRANSLATIONAL RESEARCH GRANTS

Total Grant Award from $500,000 to $750,000. - February 27, 2026 (RFP)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)
The IWMF seeks proposals to understand the mechanisms of Waldenstrom macroglobulinemia pathogenesis.

Funding Opportunity: TRANSLATIONAL RESEARCH GRANTS

Read more: TRANSLATIONAL RESEARCH GRANTS

PILOT CLINICAL TRIAL GRANTS

Each Grant will be 2-4 years in duration, with a maximum total Grant Award up to $1,000,000. - February 27, 2026 (RFP)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)
The aim is to support investigator-initiated trials to seeking distinctly novel advances and innovative approaches.

Funding Opportunity: PILOT CLINICAL TRIAL GRANTS

Read more: PILOT CLINICAL TRIAL GRANTS

TRANSLATIONAL BRIDGE AWARD

Up to $450,000 for up to 2 years - Thursday, February 19, 2026 (Application)

Lupus Research Alliance
This award funds projects advancing potential commercial entities/ clinical products with clear and direct relevance to people with lupus and the potential to improve diagnosis or the standard of care for the disease.

Funding Opportunity: TRANSLATIONAL BRIDGE AWARD

Read more: TRANSLATIONAL BRIDGE AWARD

Funding Opportunity: NIDCR SMALL RESEARCH GRANTS FOR ANALYSES OF EXISTING GENOMICS DATA (R03 CLINICAL TRIAL NOT ALLOWED)

Read more: NIDCR SMALL RESEARCH GRANTS FOR ANALYSES OF EXISTING GENOMICS DATA (R03 CLINICAL TRIAL NOT ALLOWED)